Why Akerna Shares Are Trading Higher By 97%; Here Are 20 Stocks Moving Premarket

Gainers

• Akerna Corp. (NASDAQ:KERN) rose 97.4% to $1.91 in pre-market trading after the company reported the sale of 365 Cannabis for $2.8 million.
• Yield10 Bioscience, Inc. (NASDAQ:YTEN) shares rose 49.4% to $3.14 in pre-market trading. Yield10 Bioscience and Mitsubishi Corporation signed a MOU to evaluate the establishment of a partnership to supply, offtake and market camelina as a feedstock oil for biofuel.
• Expion360 Inc. (NASDAQ:XPON) rose 47.4% to $2.33 in pre-market trading. Expion360 introduced AURA POWERCAP, a revolutionary portable powerpack accessory for e360 lithium-ion batteries.
• The Very Good Food Company Inc. (NASDAQ:VGFC) shares rose 41.4% to $0.0963 in pre-market trading. The Very Good Food Company reported that the company's secured lender intends to apply for the appointment of a receiver for the company.
• Party City Holdco Inc. (NYSE:PRTY) rose 23.7% to $0.35 in pre-market trading after dropping 37% on Wednesday.
• Bed Bath & Beyond Inc. (NASDAQ:BBBY) rose 19.8% to $4.18 in pre-market trading after adding more than 68% on Wednesday.
• Acer Therapeutics Inc. (NASDAQ:ACER) shares rose 17.5% to $3.35 in pre-market trading.
• Argo Blockchain plc (NASDAQ:ARBK) rose 15.5% to $1.20 in pre-market trading. Argo Blockchain shares dropped 18% on Wednesday after the company announced a December operational update.
• Arrival (NASDAQ:ARVL) rose 13% to $0.3051 in pre-market trading after gaining around 9% on Wednesday.
• GD Culture Group Limited (NASDAQ:GDC) rose 11.4% to $3.72 in pre-market trading.

Losers

• Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) fell 70.3% to $3.19 in pre-market trading after the company reported Wednesday that its diabetes trial missed primary endpoint.
• KNOT Offshore Partners LP (NYSE:KNOP) shares fell 30.7% to $7.27 in pre-market trading. The company’s board declared a quarterly cash distribution with respect to the quarter ended December 31, 2022, of $0.026 per common unit.
• NuCana plc (NASDAQ:NCNA) shares fell 17.8% to $1.20 in pre-market trading. NuCana recently announced receipt of NASDAQ notice.
• Logitech International S.A. (NASDAQ:LOGI) fell 16.1% to $57.22 in pre-market trading after the company reported preliminary Q3 Results and cut FY23 outlook.
• Atlis Motor Vehicles, Inc. (NASDAQ:AMV) fell 15.6% to $8.51 in pre-market. Atlis Motor Vehicles shares jumped 276% on Wednesday after the company reached 2 gigawatt-hours' worth of battery capacity in the form of customer demand.
• TRxADE HEALTH, Inc. (NASDAQ:MEDS) fell 11.6% to $0.4650 in pre-market trading after jumping 34% on Wednesday.
• Windtree Therapeutics, Inc. (NASDAQ:WINT) fell 11.1% to $0.1870 in pre-market trading.
• Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) fell 9.6% to $0.5625 in pre-market trading. Hepion Pharmaceuticals shares gained 35% on Wednesday after the company announced the presentation of a preclinical study highlighting the anti-cancer activity of rencofilstat in combination with proteosome inhibitors.
• Biora Therapeutics, Inc. (NASDAQ:BIOR) fell 9.5% to $6.06 in pre-market trading after climbing 24% on Wednesday. Biora Therapeutics has been granted U.S. patent number 11,547,301 titled "Methods For Collecting And Testing Bacteria Containing Samples From Within The Gastrointestinal Tract."
• Lipella Pharmaceuticals Inc.. (NASDAQ:LIPO) fell 9% to $3.34 in pre-market trading. Lipella Pharmaceuticals shares gained 18% on Wednesday after the company announced top line results of its Phase 2a clinical trial evaluating the safety and efficacy of its drug candidate LP-10 for Hemorrhagic Cystitis